A Study to Evaluate the Safety, Tolerability, Efficacy, Pharmacokinetics and Pharmacodynamics of M281 Administered to Adults With Generalized Myasthenia Gravis
Clinical trial NCT03772587 · COMPLETED
Trial details
- NCT number
- NCT03772587
- Sponsor
- Momenta Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-10
- Primary completion
- 2020-06-25
- Enrollment
- 68
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.